BioCentury
ARTICLE | Clinical News

Allelock olopatadine hydrochloride regulatory update

November 10, 2008 8:00 AM UTC

Kyowa said that in July it submitted a Chinese marketing application for Allelock to treat allergies. The company co-markets an eye drop formulation of the histamine H1 receptor antagonist with Alcon...